Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome

Francesco Grigioni1, Jean-François Avierinos, Lieng H Ling

  • 1Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.

Abstract

Insights

Atrial fibrillation (AF) develops frequently in patients with mitral regurgitation (MR) and is linked to increased cardiac death and heart failure. Age and left atrial size predict AF onset in MR patients.

Area of Science:

  • Cardiology
  • Valvular Heart Disease
  • Electrophysiology

Background:

  • The incidence and clinical significance of atrial fibrillation (AF) in patients with mitral regurgitation (MR) are not well-defined.
  • Understanding AF development in MR is crucial for patient management.

Purpose of the Study:

  • To determine the incidence, predictors, and prognostic impact of new-onset atrial fibrillation (AF) in patients with mitral regurgitation (MR) initially in sinus rhythm.
  • To compare AF development in MR caused by flail leaflets versus mitral valve prolapse (MVP).

Main Methods:

  • Analysis of two patient cohorts with degenerative MR in sinus rhythm: 360 with flail leaflets and 89 with MVP.
  • Echocardiographic assessment of MR severity and left atrial (LA) dimensions.
  • Long-term follow-up to ascertain AF occurrence and clinical outcomes under conservative management.

Main Results:

  • High rates of AF observed: 5-year incidence 18% and 10-year incidence 48% in flail leaflet MR.
  • AF onset was independently associated with increased risk of cardiac death or heart failure (aRR 2.23).
  • Predictors of AF included advanced age and larger LA dimension (>50 mm). AF incidence was similar for flail leaflet and MVP causes of MR.

Conclusions:

  • Degenerative MR patients in sinus rhythm have a high incidence of AF under conservative management, regardless of MR etiology (flail leaflet or MVP).
  • Onset of AF in MR is associated with increased cardiac mortality and morbidity.
  • Clinical management strategies for MR should consider the high risk and predictors of AF, including age and LA size.

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...